Document is current
Any future updates will be listed below
-
Authors
Kim, Hyeon-Jin https://orcid.org/0000-0001-6938-4602
Booth, Greg https://orcid.org/0000-0003-3748-5518
Saunders, Lauren https://orcid.org/0000-0003-4377-4252
Srivatsan, Sanjay
McFaline-Figueroa, José L. https://orcid.org/0000-0003-4387-1511
Trapnell, Cole https://orcid.org/0000-0002-8105-4347
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01HG010632, RC2DK114777)
U.S. Department of Health & Human Services | National Institutes of Health
- License Information
-
More Information
Article History
Received: 27 January 2021
Accepted: 26 April 2022
First Online: 13 May 2022
Competing interests
: C.T. is a SAB member, consultant, and/or co-founder of Algen Biotechnologies, Altius Therapeutics, and Scale Biosciences. One or more embodiments of one or more patents and patent applications filed by the University of Washington may encompass methods, reagents, and the data disclosed in this manuscript. Some work in this study is related to technology described in patent applications. All other authors declare no competing interests.
